drugset / Trial / NCT06243770
Study to Investigate Safety and Tolerability of mRNA-0184 Administered Under Different Infusion Conditions in Healthy Participants
RandomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to evaluate the safety and tolerability of intravenously (IV) administered mRNA-0184 under different infusion conditions.
Timeline
- Start
- 2024-02-16
- Primary completion
- 2025-06-12
- Completion
- 2025-06-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mRNA-0184 | Unknown | — | Intravenous |
Indications
No indication recorded.